Reversal of protein aggregation provides evidence for multiple aggregated states

被引:72
作者
Calamai, M
Canale, C
Relini, A
Stefani, M
Chiti, F
Dobson, CM
机构
[1] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England
[2] Univ Genoa, Dipartimento Fis, I-16146 Genoa, Italy
[3] Univ Florence, Dipartimento Sci Biochim, I-50134 Florence, Italy
基金
英国惠康基金;
关键词
amyloid; disaggregation kinetics; stability; refolding; size;
D O I
10.1016/j.jmb.2004.11.067
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Observations that prefibrillar aggregates from different amyloidogenic proteins can be solubilised under some conditions have raised questions as to the generality of this phenomenon and the nature of the factors that influence it. By studying aggregates formed from human muscle acylphosphatase (AcP) under mild denaturing conditions, and by using a battery of techniques, we demonstrate that disaggregation is possible under conditions close to physiological where the protein is stable in its native state. In the presence of 25% (v/v) trifluoroethanol (TFE) AcP undergoes partial unfolding and globular aggregates (60-200 nm in diameter) that can assemble further into clusters (400-800 nm in diameter) develop progressively. Yet larger superstructures (> 5 mum) are formed when the concentration of the globular aggregates exceeds a critical concentration. After diluting the sample to give a solution containing 5% TFE, the fraction of partially unfolded monomeric protein refolds very rapidly, with a rate constant of similar to 1 s(-1). The 60-200 nm globular aggregates disaggregate with an apparent rate constant of similar to 2.5 x 10(-3) s(-1) while the 400-800 run clusters disassembly more slowly with a rate constant of similar to 3.1 x 10(-4) s(-1). The larger (> 5 mum) superstructures are not disrupted under the conditions used here. These results suggest that amyloid formation occurs in discrete steps whose reversibility is increasingly difficult, and dependent on the size of the aggregates, and that disaggregation experiments can provide a powerful method of detecting different types of species within the complex process of aggregation. In addition, our work suggests that destabilization of amyloid aggregates resulting in the conversion of misfolded proteins back to their native states could be an important factor in both the onset and treatment of diseases associated with protein aggregation. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:603 / 616
页数:14
相关论文
共 67 条
[31]   Aggresomes, inclusion bodies and protein aggregation [J].
Kopito, RR .
TRENDS IN CELL BIOLOGY, 2000, 10 (12) :524-530
[32]   Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the β-domain [J].
Krebs, MRH ;
Wilkins, DK ;
Chung, EW ;
Pitkeathly, MC ;
Chamberlain, AK ;
Zurdo, J ;
Robinson, CV ;
Dobson, CM .
JOURNAL OF MOLECULAR BIOLOGY, 2000, 300 (03) :541-549
[33]   The formation of spherulites by amyloid fibrils of bovine insulin [J].
Krebs, MRH ;
MacPhee, CE ;
Miller, AF ;
Dunlop, IE ;
Dobson, CM ;
Donald, AM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (40) :14420-14424
[34]   Novel pharmacological strategies in amyloidosis [J].
Lachmann, HJ ;
Hawkins, PN .
NEPHRON CLINICAL PRACTICE, 2003, 94 (04) :C85-C88
[35]   Reversible amyloid formation by the p53 tetramerization domain and a cancer-associated mutant [J].
Lee, AS ;
Galea, C ;
DiGiammarino, EL ;
Jun, B ;
Murti, G ;
Ribeiro, RC ;
Zambetti, G ;
Schultz, CP ;
Kriwacki, RW .
JOURNAL OF MOLECULAR BIOLOGY, 2003, 327 (03) :699-709
[36]   Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: Implications for initial events in amyloid plaque formation [J].
Lemere, CA ;
Blusztajn, JK ;
Yamaguchi, H ;
Wisniewski, T ;
Saido, TC ;
Selkoe, DJ .
NEUROBIOLOGY OF DISEASE, 1996, 3 (01) :16-32
[37]  
Lomakin A, 1999, METHOD ENZYMOL, V309, P429
[38]   Chemical dissection and reassembly of amyloid fibrils formed by a peptide fragment of transthyretin [J].
MacPhee, CE ;
Dobson, CM .
JOURNAL OF MOLECULAR BIOLOGY, 2000, 297 (05) :1203-1215
[39]   Examining the structure of the mature amyloid fibril [J].
Makin, OS ;
Serpell, LC .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2002, 30 :521-525
[40]   COMPARISON OF LETHAL AND NONLETHAL TRANSTHYRETIN VARIANTS AND THEIR RELATIONSHIP TO AMYLOID DISEASE [J].
MCCUTCHEN, SL ;
LAI, ZH ;
MIROY, GJ ;
KELLY, JW ;
COLON, W .
BIOCHEMISTRY, 1995, 34 (41) :13527-13536